← All organizations
Highest phase reached
Phase 1
First clinical trial
Jun 22, 2020Last known activity
Sep 8, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 9 trials)
Phase 1 (1 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07174323OfficialN/ASep 8, 2025
- NCT07174323Lead sponsorN/ASep 8, 2025
- NCT07075822OfficialN/AJun 11, 2025
- NCT07075822Lead sponsorN/AJun 11, 2025
- NCT06294938OfficialN/ASep 30, 2022
- NCT06294938CollaboratorN/ASep 30, 2022
- NCT05587426Overall official - principal investigatorN/AJun 3, 2022
- NCT05264636CollaboratorN/AFeb 11, 2022
- NCT05179031CollaboratorN/AJan 4, 2022
- NCT05185960CollaboratorN/ASep 15, 2021
- NCT04869215Overall official - principal investigatorN/AMay 31, 2021
- NCT04869215CollaboratorN/AMay 31, 2021
- NCT04507971Overall official - principal investigatorPhase 1Jun 22, 2020
Details
- Founded
- Toronto, CA
- Last known activity
- Sep 8, 2025